, Tracking Stock Market Picks
Enter Symbol:
Neurometrix, Inc. (NURO) [hlAlert]

down 95.33 %

Neurometrix, Inc. (NURO) upgraded to Buy with price target $5 by Stanford Research

Posted on: Monday,  Oct 27, 2008  9:25 AM ET by Stanford Research

Stanford Research rated Buy Neurometrix, Inc. (NASDAQ: NURO) on 10/27/2008, when the stock price was $19.08. Since
then, Neurometrix, Inc. has lost 95.34% as of 01/04/2016's recent price of $0.89.
If you would have followed this Stanford Research's recommendation on NURO, you would have lost 95.33% of your investment in 2625 days.

Neurometrix is a medical device company establishing a new standard of care through the design, development and sale of proprietary products used to diagnose neuropathies. Neuropathies are diseases of the peripheral nerves and parts of the spine that frequently are caused by or associated with diabetes, low back pain and carpal tunnel syndrome, as well as other clinical disorders.

Stanford Research encompasses both institutional equity research and Washington-focused policy research, offering a perspective on individual companies, sector-specific topics and national policy. The importance Stanford Group Company places on research comes from years of experience in a constantly changing world. We know that as markets develop and new sectors grow, it is imperative that our clients have the most accurate information available to ensure financial success. Stanford Group Company clients will always have our commitment to conduct informative and enlightening research. As a part of our commitment to our clients, we provide objective, well-developed research. Our skilled analysts use their talent to provide invaluable research that can help in making important decisions. Thanks to a wide range of resources obtained through technology, experience and reputation, our research analysts develop reports on the most current firms and sectors. Our equity analysts offer insight and opinions on companies in the consumer/retail, media, energy, financial institutions, health care, technology and water/environment sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/27/2008 9:25 AM Buy
19.08 180.00
as of 12/24/2008
1 Week up  4.54 %
1 Month up  15.82 %
3 Months up  54.79 %
1 YTD up  85.05 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/11/2008 9:25 AM Hold
194.40 360.00
10/9/2007 9:25 AM Buy

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy